Q Fever Vaccines: Unveiling the Historical Journey and Contemporary Innovations in Vaccine Development by Magdalini Christodoulou, Dimitrios Papagiannis

Subjects: Get full text

Evaluation of the Reactogenicity, Safety and Immunogenicity of the Domestic Influenza Inactivated Split FLU-M Vaccine in Immunization Adults aged 18–60 Years by I. V. Fel'dblyum, S. D. Novgorodova, G. M. Ignat'ev, S. O. Golodnova, V. P. Trukhin, S. Ya Melnikov

Subjects: Get full text

Safety and reactogenicity of the BNT162b2 COVID-19 vaccine: Development, post-marketing surveillance, and real-world data by Frank van den Ouweland, Nicola Charpentier, Özlem Türeci, Ruben Rizzi, Federico J. Mensa, Claudia Lindemann, Shanti Pather

Subjects: Get full text

Observational Safety Study of Meningococcal Conjugate Vaccine Against Serogroups A, C, W and Y (Menactra) Used in Routine Healthcare Practice for Persons Aged 2 to 55 Years in Ru... by I. Ya. Izvekova, L. S. Namazova-Baranova, A. V. Gogolev, L. V. Dubova, V. V. Romanenko, E. V. Zinnatova, G. P. Martynova, Y. Thollot, A. Paye, A. V. Goldstein

Subjects: Get full text

Immunogenicity and Reactogenicity of Francisella tularensis Strain 15/23-1 recA - the Candidate for a New Live Tularemia Vaccine by A. N. Mokrievich, G. M. Titareva, T. I. Kombarova, E. A. Ganina, T. B. Kravchenko, I. V. Bakhteeva, G. M. Vakhrameeva, R. I. Mironova, A. I. Borzilov, O. V. Korobova, V. M. Pavlov, I. A. Dyatlov

Subjects: Get full text

Safety and Immunogenicity of Meningococcal Groups A and C Polysaccharide Vaccine in Adults 18–60 years of age by V. V. Romanenko, B. I. Kuzubov, N. A. Tsukanova, A. A. Kotova

Subjects: Get full text

Comparative Randomized Study of Tolerability, Reactogenicity, Immunogenicity and Safety of the Vaccine «BiVac Polio» (Oral Poliovirus Vaccine Type 1,3) by Yu. H. Khapchaev, O. E. Ivanova, M. F. Vorovitch, V. V. Romanenko, A. E. Makarov, S. G. Drozdov, A. A. Ishmukhametov

Subjects: Get full text

Safety and Immunogenicity of a Modified Self-Amplifying Ribonucleic Acid (saRNA) Vaccine Encoding SARS-CoV-2 Spike Glycoprotein in SARS-CoV-2 Seronegative and Seropositive Ugandan... by Jonathan Kitonsa, Jennifer Serwanga, Hannah M. Cheeseman, Andrew Abaasa, Jane Frances Lunkuse, Eugene Ruzagira, Laban Kato, Florence Nambaziira, Gerald Kevin Oluka, Ben Gombe, Sembera Jackson, Joseph Katende Ssebwana, Leon R. McFarlane, Sarah Joseph, Benjamin F. Pierce, Robin J. Shattock, Pontiano Kaleebu

Subjects: “…vaccine safety and reactogenicity…”
Get full text

Influence of the reactogenity of the tick-borne encephalitis vaccines on the immune response in vaccinated people by G. N. Leonova, N. V. Krylova, Ye. V. Pavlenko, O. S. Maystrovskaya

Subjects: Get full text